220 related articles for article (PubMed ID: 25404736)
21. Curcumin has immunomodulatory effects on RANKL-stimulated osteoclastogenesis in vitro and titanium nanoparticle-induced bone loss in vivo.
Yang C; Zhu K; Yuan X; Zhang X; Qian Y; Cheng T
J Cell Mol Med; 2020 Jan; 24(2):1553-1567. PubMed ID: 31845532
[TBL] [Abstract][Full Text] [Related]
22. The Implant-Induced Foreign Body Response Is Limited by CD13-Dependent Regulation of Ubiquitination of Fusogenic Proteins.
Ghosh M; McGurk F; Norris R; Dong A; Nair S; Jellison E; Murphy P; Verma R; Shapiro LH
J Immunol; 2024 Feb; 212(4):663-676. PubMed ID: 38149920
[TBL] [Abstract][Full Text] [Related]
23. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B
J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855
[TBL] [Abstract][Full Text] [Related]
24. Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells.
Miyamoto H; Suzuki T; Miyauchi Y; Iwasaki R; Kobayashi T; Sato Y; Miyamoto K; Hoshi H; Hashimoto K; Yoshida S; Hao W; Mori T; Kanagawa H; Katsuyama E; Fujie A; Morioka H; Matsumoto M; Chiba K; Takeya M; Toyama Y; Miyamoto T
J Bone Miner Res; 2012 Jun; 27(6):1289-97. PubMed ID: 22337159
[TBL] [Abstract][Full Text] [Related]
25. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells.
Jones JA; Chang DT; Meyerson H; Colton E; Kwon IK; Matsuda T; Anderson JM
J Biomed Mater Res A; 2007 Dec; 83(3):585-96. PubMed ID: 17503526
[TBL] [Abstract][Full Text] [Related]
26. Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells.
Blüml S; Friedrich M; Lohmeyer T; Sahin E; Saferding V; Brunner J; Puchner A; Mandl P; Niederreiter B; Smolen JS; Schabbauer G; Redlich K
Ann Rheum Dis; 2015 Jan; 74(1):227-33. PubMed ID: 24078675
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of biochanin A on titanium particle-induced osteoclast activation and inflammatory bone resorption via NF-κB and MAPK pathways.
Liao S; Feng W; Liu Y; Wang Z; Ding X; Song F; Lin X; Song H; Kc A; Su Y; Liang J; Xu J; Liu Q; Zhao J
J Cell Physiol; 2021 Feb; 236(2):1432-1444. PubMed ID: 32853427
[TBL] [Abstract][Full Text] [Related]
28. Decoy Receptor 3 Promotes Preosteoclast Cell Death via Reactive Oxygen Species-Induced Fas Ligand Expression and the IL-1
Peng YJ; Peng CT; Lin YH; Lin GJ; Huang SH; Chen SJ; Sytwu HK; Cheng CP
Mediators Inflamm; 2020; 2020():1237281. PubMed ID: 32587467
[TBL] [Abstract][Full Text] [Related]
29. Diversity of multinucleated giant cells by microstructures of hydroxyapatite and plasma components in extraskeletal implantation model.
Morishita K; Tatsukawa E; Shibata Y; Suehiro F; Kamitakahara M; Yokoi T; Ioku K; Umeda M; Nishimura M; Ikeda T
Acta Biomater; 2016 Jul; 39():180-191. PubMed ID: 27154501
[TBL] [Abstract][Full Text] [Related]
30. Connexin 43 expression of foreign body giant cells after implantation of nanoparticulate hydroxyapatite.
Herde K; Hartmann S; Brehm R; Kilian O; Heiss C; Hild A; Alt V; Bergmann M; Schnettler R; Wenisch S
Biomaterials; 2007 Nov; 28(33):4912-21. PubMed ID: 17719629
[TBL] [Abstract][Full Text] [Related]
31. A small molecule potent IRAK4 inhibitor abrogates lipopolysaccharide-induced macrophage inflammation in-vitro and in-vivo.
Choudhary SA; Patra D; Sinha A; Mazumder S; Pant R; Chouhan R; Jha AN; Prusty BM; Manna D; Das SK; Tikoo K; Pal D; Dasgupta S
Eur J Pharmacol; 2023 Apr; 944():175593. PubMed ID: 36804543
[TBL] [Abstract][Full Text] [Related]
32. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
Hsieh TP; Sheu SY; Sun JS; Chen MH
Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
[TBL] [Abstract][Full Text] [Related]
33. Giant cells around bone biomaterials: Osteoclasts or multi-nucleated giant cells?
Miron RJ; Zohdi H; Fujioka-Kobayashi M; Bosshardt DD
Acta Biomater; 2016 Dec; 46():15-28. PubMed ID: 27667014
[TBL] [Abstract][Full Text] [Related]
34. Aminothiazoles inhibit osteoclastogenesis and PGE
Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
[TBL] [Abstract][Full Text] [Related]
35. Differential roles of MAPK kinases MKK3 and MKK6 in osteoclastogenesis and bone loss.
Boyle DL; Hammaker D; Edgar M; Zaiss MM; Teufel S; David JP; Schett G; Firestein GS
PLoS One; 2014; 9(1):e84818. PubMed ID: 24400116
[TBL] [Abstract][Full Text] [Related]
36. Blockade of NF-κB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo.
Ru JY; Xu HD; Shi D; Pan JB; Pan XJ; Wang YF
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27638499
[TBL] [Abstract][Full Text] [Related]
37. Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation.
Darowish M; Rahman R; Li P; Bukata SV; Gelinas J; Huang W; Flick LM; Schwarz EM; O'Keefe RJ
Bone; 2009 Oct; 45(4):661-8. PubMed ID: 19524707
[TBL] [Abstract][Full Text] [Related]
38. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
[TBL] [Abstract][Full Text] [Related]
39. Mechanotransduction via a TRPV4-Rac1 signaling axis plays a role in multinucleated giant cell formation.
Arya RK; Goswami R; Rahaman SO
J Biol Chem; 2021; 296():100129. PubMed ID: 33262217
[TBL] [Abstract][Full Text] [Related]
40. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
